Step 1 topics → Endocrine → Cushing Disease (ACTH-Secreting Pituitary Adenoma)

Cushing Disease (ACTH-Secreting Pituitary Adenoma)

USMLE Step 1 trap: Conflates Cushing disease (pituitary ACTH adenoma) with Cushing syndrome (any cause of cortisol excess). Cushing syndrome is the clinical state of cortisol excess from any cause; Cushing disease specifically refers to an ACTH-secreting pituitary adenoma as the cause.

Cushing disease is a high-yield pituitary topic on USMLE Step 1, and the biggest trap is terminology — students conflate 'Cushing disease' (a pituitary ACTH-secreting adenoma specifically) with 'Cushing syndrome' (cortisol excess from any source). The exam exploits this ruthlessly because the workup and management differ depending on the specific etiology. Students also jump straight to ACTH measurement before confirming cortisol excess, reversing the diagnostic logic. The correct sequence: confirm hypercortisolism first, then check ACTH, then localize the source.

The biggest trap is terminology. Students constantly conflate 'Cushing disease' with 'Cushing syndrome,' and USMLE Step 1 exploits this ruthlessly. Cushing syndrome is the clinical picture of cortisol excess from any source — exogenous steroids, adrenal tumor, ectopic ACTH, or pituitary adenoma. Cushing disease is one specific cause: the pituitary adenoma. The distinction matters because the workup, localization, and management differ entirely depending on the source.

The second major trap is workup sequence. Students want to jump straight to measuring ACTH, but the correct framework always establishes cortisol excess first. Only after confirming hypercortisolism do you check ACTH to distinguish ACTH-dependent from ACTH-independent causes — and only then do you work to localize the ACTH source. If you have that sequence locked in, you'll handle the diagnostic questions with confidence. If you don't, you'll keep choosing 'measure ACTH' when the right answer is still 'confirm cortisol excess.'

From real student decks
43%have cards covering this topic
14%have mature cards

Common misconceptions

Common mistake
Wrong: Students use 'Cushing disease' and 'Cushing syndrome' interchangeably.
Right: Cushing syndrome is the clinical state of cortisol excess from any cause; Cushing disease specifically refers to an ACTH-secreting pituitary adenoma as the cause.
Cushing syndrome describes the clinical state of cortisol excess regardless of cause — this includes exogenous steroids, adrenal adenomas, ectopic ACTH secretion, and pituitary adenomas. Cushing disease is a subset: it refers exclusively to a pituitary ACTH-secreting adenoma as the cause. Using these terms interchangeably will cost you points on USMLE Step 1 because the exam often asks you to identify the specific etiology or pick a workup step that only applies to one cause and not the other.
Common mistake
Wrong: The first step in evaluating suspected Cushing disease is measuring ACTH.
Right: The first step is to confirm cortisol excess (24-hour urine free cortisol, late-night salivary cortisol, or low-dose dexamethasone suppression test); ACTH measurement comes only after cortisol excess is established.
Measuring ACTH before confirming cortisol excess reverses the logic of the workup. ACTH tells you whether hypercortisolism is ACTH-driven, but if you haven't confirmed hypercortisolism yet, that information is meaningless. The first step is always to establish that cortisol excess exists (via 24-hour urine free cortisol, late-night salivary cortisol, or low-dose dexamethasone suppression); only then does measuring ACTH help you distinguish ACTH-dependent from ACTH-independent causes.
Common mistake
Gap: Misses the role of petrosal sinus sampling in distinguishing pituitary from ectopic ACTH when MRI is negative or equivocal
Inferior petrosal sinus sampling (IPSS) measures the ACTH gradient between petrosal sinus blood and peripheral blood to distinguish a pituitary source (high gradient) from an ectopic ACTH source (no gradient) when imaging is inconclusive.
When a patient has confirmed ACTH-dependent Cushing syndrome but MRI of the pituitary is negative or shows an equivocal lesion, you can't assume the source is pituitary. IPSS solves this by directly sampling venous blood draining the pituitary — a petrosal-to-peripheral ACTH ratio above 2 (or above 3 after CRH stimulation) confirms the pituitary as the source, while a low ratio redirects the workup toward ectopic ACTH (e.g., small cell lung cancer, carcinoid). This test is high-yield because it changes management entirely.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. The exam tests your ability to apply the stepwise diagnostic framework: confirm cortisol excess first (24-hour urine free cortisol, late-night salivary cortisol, or low-dose dexamethasone suppression test), then check ACTH to determine dependence, then localize the source — in that order.
  2. The exam tests whether you understand inferior petrosal sinus sampling (IPSS): when MRI is negative or equivocal in a patient with ACTH-dependent Cushing syndrome, IPSS measures the ACTH gradient between petrosal sinus blood and peripheral blood — a high gradient confirms a pituitary source, while no gradient points to ectopic ACTH.
  3. The exam tests first-line management of Cushing disease: transsphenoidal resection of the pituitary adenoma is the primary treatment, with medical options (ketoconazole, metyrapone, pasireotide) used as adjuncts or when surgery fails.

Can you avoid these mistakes?

A 34-year-old woman presents with central obesity, purple striae, and proximal muscle weakness. Her 24-hour urine free cortisol is elevated. What is the next step in the workup, and what result would point you toward a pituitary source versus an adrenal source?
A patient has confirmed ACTH-dependent hypercortisolism. MRI of the pituitary shows no adenoma. What test do you order next, and how do you interpret a central-to-peripheral ACTH ratio of 3.5 after CRH stimulation?
Your attending says the patient has 'Cushing disease.' The patient asks if her adrenal glands are involved. What do you tell her about why both adrenal glands are enlarged even though the problem started in her pituitary?
A patient with Cushing disease undergoes successful transsphenoidal resection. Postoperatively, you expect her cortisol to drop. Why might she need glucocorticoid supplementation in the weeks following surgery, and what physiologic mechanism explains this?

Related topics

Hypothalamic-Pituitary-Adrenal (HPA) Axis Hypothalamic-Pituitary-Thyroid (HPT) Axis Hypothalamic-Pituitary-Gonadal (HPG) Axis Hormone Signaling (Peptide vs Steroid)

See how your Anki deck covers this topic.

Upload your deck for a free audit →